Macro Dragon: The Price Action = The Price Action Macro Dragon: The Price Action = The Price Action Macro Dragon: The Price Action = The Price Action

Macro Dragon: The Price Action = The Price Action

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon touches on the blazing price action overnight, as the S&P clocked its best session since August with a +1.5% uplift to 3298 - apparently the coronavirus is something to sneeze at. The price actions is the price action. And of course we check in on 2019-nCoV, the completion of the two hospitals in c. 10 days - incredible! Will likely see a jump in confirmed cases & fall in suspected cases. Asia Wed Open is looking bullish.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)



Macro Dragon: The Price Action = The Price Action  


Overnight Risk-On & thoughts…

  • We had the biggest one day pop up in the SPX since Aug, with a +1.5% move on cash to 3298. It was also a case of Iowa causes be damned, as the Democratic party completely face planted in their handling of the Caucuses which ended up with as of this Morning Asia Weds – still no official winner.
  • Likely good for Biden who looks like he will finish 4th, yet bad for Peter-B who looks like he crushed it – at 38yr old & gay, this is a welcome surprise to KVP, who did not expect the Iowa voters to be so woke. Worth noting that Iowa is far from representative to the rest of the country, yet this could give Peter-B some afterburners he would never have gotten, its also almost assures that he will run in 2024 if Trump stays. KVP still thinks an ACE move, other than ACO for VP (Apparently at 30, that’s too you), but Peter-B would be an awesome VP to either Warren, Bernie or Biden…
  • This one tweet captured the Iowa process more eloquently than any words that we can construe together on Macro Dragon.
  • Kudos to clients & peers who were nimble enough to play the squeeze higher & flexible enough to turn their tactical books around after being right & profitably bearish coming into this wk.
  • Macro Dragon came into this wk with  bearish skew & the thinking that – at least for this stage of the coronavirus – we were going to see max bearishness peak in this wk to latest early next week… yet super surprised to see how strong Asia & China was out the gates on Monday. Yes DollarYen downside was a great call from last wk, yet only lasted until Mon Morning Asia – still 80 pips is 80 pips. And tactical gold shorts overnight worked well as a play on the risk-on, as the price action on gold on any risk-off continues to be abysmal.
  • This was on the Saxo Wire this morning.
  • Asia Wed Open: O/N saw biggest S&P gain since Aug, with +1.5% 3298, Nas-100 +2.3% 9334, DAX +1.79% 13274, HSI was +1.21% 26676, VIX -10.7% to 16.05. Iowa = disaster with no clear results. Gold -1.51% to 1553, UST 1.6077, USDJPY +0.76% 109.52, USDCNH -0.33% 6.9908. Risk-on start
  • Call it liquidity, call it FOMO, call it a synthetic market, call it buy the dip, call it the blowoff top effect, yet from a US equities side we only managed a c. -3.70% drawdown from the highs. The astounding thing is, before the sell-off the positioning on the long side was the biggest we had seen by almost any measures out there.
  • One key takeaway for KVP is again – don’t play risk-off with US equities… do it either with treasuries (which should be a core long anyway, just have a trading clip) or equities that have underlying EZ, EM or Asia exposure.
  • Also don’t mistake the day to day price action for the underlying fundamentals – the deflationary shock will still feed through both economic data & corporate earnings (&not just Chinese/Asian company earnings… but your Apples, US Autos, Star$, Macau gaming names – city closed down operations for half a month, etc), as well as have positive impact on things like Tencent, Baba… think content, streaming, delivery, services in China that limit need for contact or stepping out of your home, office, etc.  
  • And definitely don’t mistake it for the virus being nipped in the bud, yet we do know there will come a time when markets stop to care about the coronavirus. Question is, has that time come now? KVP is unsure… what he is sure of… there will be more higher probability tactical situations at some point & for now, the price action is the price action.
  • Again, KVP would neither be surprised if we got obsessed with the Virus again (perhaps Asia will disconnect from the US) & reversed or kept selling off. So tactically neutral on price action, still strategically long US duration – clearest takeaways behind this still stand. The probability of a Fed cut & magnitude of that cut have increased post this deflationary shock & KVP can envisage a 2020 where US10s get sub 1.00% from these 1.61%.
  • Obvious key risk is overestimating this deflationary shock & potential overlooking of the pullback in economic activity & corporate earnings for the stimulus that would come and/or a much stronger US economy that picks up the slack that we lose from a temporary weaker China & Asia.
  • Do watch out for US ISM Non-Mfg. figures tonight 55.1e 55.0p, these will be post the blowout beats we got on the mfg. on Mon 50.9a 48.5e 47.2p – which no doubt contributed to the bulls finding legs.
  • Before that we should be getting Trumps State of the Union that should be kicking off 21:00 ET, c 10:00 SGT/HKT/CST

2019-nCoV Update Wed Asia Mrn 5 Feb…

Quick update & thoughts on the Virus since Tue check in:

  • China can do the impossible!
  • Let KVP repeat this again. China can do the impossible. Two hospitals in c. 10days, there is no other country on this planet… let alone the US (probably takes 2yrs just to get the permits)… that could accomplish that. In fact China’s ability to concentrate a huge volume of the smartest people on the planet, with unlimited resources & no rule book is a godlike edge, that no other country-institution-group can match. So with these hospitals now starting to accept new patients, intuitively we should see a jump in confirmed cases as the suspected cases are well over 20,000.   
  • As of this Wed Asia morning, the “official figures” are at c. 24,553 confirmed cases, +492 deaths & c. 852 recovered. KVP reckons closer conservative number of infected is likely +25,000 to 50,000 on the mainland… & before its all over we are likely going to be well in the 6 figures… if we are not yet there.
  • We did have some pretty big jumps in effected outside of China: With +6 in Thailand to 25, +6 in Singapore to 24 (& these were passed on in SG, i.e. not the classic case of someone from Wuhan/Hubei going somewhere else & being ill there), +2 in Japan to 22, +2 in HK to 17, +1 in SK to 16, +1 in Au to 13, +2 in GER to 12, +1 in Taiwan to 11 & now we have Macau as well as Malaysia entering our minimum 10 cases list.



Have a fantastic wk ahead everyone, good luck on the month start, stay healthy as well as keep your mind open to profitable & abundant opportunities. Life happens for us, not to us. 




Some Anchor Pieces from #SaxoStrats:


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.